Although some see $1.75 as the floor, I still think there's some risk albeit very small that Merck will pull out or there's a no vote. I have a slight conflict of interest too, as I hold Imugene and they could easily become T cell therapies worst nightmare.
But other opportunities are calling. If they weren't I would have held on, as a Bristol MS counter offer makes sense to me, although I had it in my head that that would happen before the 5th May - which is soon upon us.
Best of luck to holders, and thanks for all the posts over the years.
I was lucky to be in at about 30c, but would have sold out long ago if it wasn't for the good posts from HC members.
ps. Even though I have sold out I would still be happy for a counter bid to come. Always pleased to see fellow investors do well, and would be another boost to the Aussie biotech sector.